"The ruling is expected to be made in mid October, 15 months after Shenzhen SiBiono filed the litigation asking Peng to return the patents for Gendicine, which were approved in his name."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.